PubRank

Vincent Mooser

Author PubWeight™ 376.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010 28.21
2 Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2008 22.35
3 Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010 20.01
4 New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010 17.89
5 Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet 2008 16.92
6 Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008 15.94
7 Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011 13.25
8 Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011 13.25
9 Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009 12.44
10 Prepublication data sharing. Nature 2009 12.24
11 Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 2009 12.19
12 Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012 12.10
13 Variants in MTNR1B influence fasting glucose levels. Nat Genet 2008 10.85
14 Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet 2010 8.55
15 An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science 2012 7.94
16 Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 2010 6.66
17 LDL-cholesterol concentrations: a genome-wide association study. Lancet 2008 6.44
18 A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet 2009 6.31
19 Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet 2009 5.81
20 The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 2008 5.33
21 Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 2009 5.32
22 Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 2009 4.97
23 The Population Reference Sample, POPRES: a resource for population, disease, and pharmacological genetics research. Am J Hum Genet 2008 4.79
24 Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet 2008 4.69
25 A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 2012 4.37
26 Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol 2010 4.08
27 Genetic loci influencing kidney function and chronic kidney disease. Nat Genet 2010 3.75
28 Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet 2011 3.40
29 Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet 2010 3.37
30 Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet 2013 3.25
31 Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet 2012 3.21
32 Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet 2011 3.18
33 Genetic variation in LIN28B is associated with the timing of puberty. Nat Genet 2009 3.09
34 Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet 2011 2.73
35 CUBN is a gene locus for albuminuria. J Am Soc Nephrol 2011 2.70
36 Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. Nature 2011 2.59
37 Use of genome-wide association studies for drug repositioning. Nat Biotechnol 2012 2.51
38 Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet 2012 2.12
39 A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet 2009 2.09
40 Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption. Proc Natl Acad Sci U S A 2011 2.01
41 Male-pattern baldness susceptibility locus at 20p11. Nat Genet 2008 1.87
42 Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 2009 1.78
43 A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One 2012 1.72
44 A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am J Hum Genet 2004 1.71
45 Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet 2010 1.67
46 Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index. Int J Epidemiol 2011 1.61
47 High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study. Ann Intern Med 2002 1.58
48 Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study. Atherosclerosis 2007 1.36
49 Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol 2005 1.32
50 Dose-dependent positive association between cigarette smoking, abdominal obesity and body fat: cross-sectional data from a population-based survey. BMC Public Health 2011 1.32
51 The PsyCoLaus study: methodology and characteristics of the sample of a population-based survey on psychiatric disorders and their association with genetic and cardiovascular risk factors. BMC Psychiatry 2009 1.29
52 Design of the Genetics of Early Onset Cardiovascular Disease (GENECARD) study. Am Heart J 2003 1.28
53 Metagenomics: the role of the microbiome in cardiovascular diseases. Curr Opin Lipidol 2006 1.25
54 Genome-wide meta-analysis for serum calcium identifies significantly associated SNPs near the calcium-sensing receptor (CASR) gene. PLoS Genet 2010 1.25
55 Genetic architecture of ambulatory blood pressure in the general population: insights from cardiovascular gene-centric array. Hypertension 2010 1.22
56 Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study. Eur J Cardiovasc Prev Rehabil 2009 1.22
57 Meta-analysis of the INSIG2 association with obesity including 74,345 individuals: does heterogeneity of estimates relate to study design? PLoS Genet 2009 1.18
58 Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases. PLoS Genet 2012 1.14
59 Alcohol drinking and cardiovascular risk in a population with high mean alcohol consumption. Am J Cardiol 2008 1.12
60 A genome-wide association study of neuroticism in a population-based sample. PLoS One 2010 1.09
61 Nutrigenomics and nutrigenetics. Curr Opin Lipidol 2004 1.09
62 Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease. Am J Clin Nutr 2013 1.08
63 Genetic evidence for a role of adiponutrin in the metabolism of apolipoprotein B-containing lipoproteins. Hum Mol Genet 2009 1.08
64 Insulin-secreting beta-cell dysfunction induced by human lipoproteins. J Biol Chem 2003 1.08
65 Prevalence of obesity and abdominal obesity in the Lausanne population. BMC Public Health 2008 1.05
66 Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol Aging 2008 1.03
67 Methods for testing association between uncertain genotypes and quantitative traits. Biostatistics 2010 1.02
68 Deep resequencing unveils genetic architecture of ADIPOQ and identifies a novel low-frequency variant strongly associated with adiponectin variation. Diabetes 2012 1.00
69 Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia. J Lipid Res 2005 1.00
70 Carriage of the V279F null allele within the gene encoding Lp-PLA₂ is protective from coronary artery disease in South Korean males. PLoS One 2011 0.99
71 Association between C-reactive protein and adiposity in women. J Clin Endocrinol Metab 2009 0.98
72 Genetic and functional association of FAM5C with myocardial infarction. BMC Med Genet 2008 0.96
73 Effects of particulate matter on inflammatory markers in the general adult population. Part Fibre Toxicol 2012 0.94
74 Association between variants of the leptin receptor gene (LEPR) and overweight: a systematic review and an analysis of the CoLaus study. PLoS One 2011 0.92
75 Contribution of major cardiovascular risk factors to familial premature coronary artery disease: the GENECARD project. J Am Coll Cardiol 2002 0.92
76 Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland. Eur J Cardiovasc Prev Rehabil 2008 0.91
77 Distribution of plasma levels of adiponectin and leptin in an adult Caucasian population. Clin Endocrinol (Oxf) 2009 0.91
78 Not all inflammatory markers are linked to kidney function: results from a population-based study. Am J Nephrol 2012 0.91
79 Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study. BMC Public Health 2011 0.90
80 Hyperlipidemia in HIV-infected children treated with protease inhibitors: relevance for cardiovascular diseases. J Acquir Immune Defic Syndr 2002 0.89
81 Prevalence, treatment and control of dyslipidaemia in Switzerland: still a long way to go. Eur J Cardiovasc Prev Rehabil 2010 0.88
82 Predictive accuracy of original and recalibrated Framingham risk score in the Swiss population. Int J Cardiol 2008 0.88
83 Genome-wide association study identifies two loci strongly affecting transferrin glycosylation. Hum Mol Genet 2011 0.87
84 Identification and validation of copy number variants using SNP genotyping arrays from a large clinical cohort. BMC Genomics 2012 0.86
85 Prevalence of normal weight obesity in Switzerland: effect of various definitions. Eur J Nutr 2008 0.85
86 Androgenetic alopecia: identification of four genetic risk loci and evidence for the contribution of WNT signaling to its etiology. J Invest Dermatol 2013 0.85
87 Patients' sibling history was sensitive for hypertension and specific for diabetes. J Clin Epidemiol 2004 0.84
88 Genetic deficiency of plasma lipoprotein-associated phospholipase A2 (PLA2G7 V297F null mutation) and risk of Alzheimer's disease in Japan. J Alzheimers Dis 2010 0.83
89 Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia. J Clin Endocrinol Metab 2007 0.83
90 The APOE locus and the pharmacogenetics of lipid response. Curr Opin Lipidol 2002 0.83
91 Surrogate markers for atherosclerosis in overweight subjects with atherogenic dyslipidemia: the GEMS project. Angiology 2008 0.82
92 Serum calcium levels are associated with novel cardiometabolic risk factors in the population-based CoLaus study. PLoS One 2011 0.82
93 FGF21 signalling pathway and metabolic traits - genetic association analysis. Eur J Hum Genet 2010 0.81
94 Truncated robust distance for clinical laboratory safety data monitoring and assessment. J Biopharm Stat 2012 0.80
95 Pharmacological effects of lipid-lowering drugs recapitulate with a larger amplitude the phenotypic effects of common variants within their target genes. Pharmacogenet Genomics 2008 0.80
96 High prevalence of major cardiovascular risk factors in first-degree relatives of individuals with familial premature coronary artery disease--the GENECARD project. Atherosclerosis 2006 0.79
97 Involvement of 4E-BP1 in the protection induced by HDLs on pancreatic beta-cells. Mol Endocrinol 2009 0.79
98 Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension. Hum Mol Genet 2012 0.79
99 Association of ABCB1 genetic variants with renal function in Africans and in Caucasians. BMC Med Genomics 2008 0.78
100 Short-term administration of isotretinoin elevates plasma triglyceride concentrations without affecting insulin sensitivity in healthy humans. Metabolism 2004 0.78
101 Efficacy and safety of fluvastatin in hyperlipidemic protease inhibitor-treated HIV-infected patients. AIDS 2002 0.78
102 Reply to Rational drug repositioning by medical genetics. Nat Biotechnol 2013 0.78
103 A genomewide association study of smoking relapse in four European population-based samples. Psychiatr Genet 2013 0.77
104 Pathway-Wide Association Study Implicates Multiple Sterol Transport and Metabolism Genes in HDL Cholesterol Regulation. Front Genet 2011 0.75
105 Prospective study of insulin-like growth factor-I, insulin-like growth factor-binding protein 3, genetic variants in the IGF1 and IGFBP3 genes and risk of coronary artery disease. Int J Mol Epidemiol Genet 2011 0.75
106 European lipoprotein club: report of the 25th ELC annual conference. Tutzing, 9-12 September 2002. Atherosclerosis 2003 0.75
107 Use of constant denaturant capillary electrophoresis of pooled blood samples to identify single-nucleotide polymorphisms in the genes (Scnn1a and Scnn1b) encoding the alpha and beta subunits of the epithelial sodium channel. Clin Chem 2002 0.75
108 'Omic' approaches and lipid metabolism: are these new technologies holding their promises? Curr Opin Lipidol 2003 0.75
109 Glucose-induced insulin secretion in dyslipidemic and normolipidemic patients with normal glucose tolerance. Diabetes Care 2005 0.75
110 Cardiovascular risk estimation and eligibility for statins in primary prevention comparing different strategies. Am J Cardiol 2009 0.75
111 Smoking offsets the metabolic benefits of parental longevity in women: the CoLaus study. Prev Med 2008 0.75
112 Genes, lipids and aging: is it all accounted for by cardiovascular disease risk?: editorial review. Curr Opin Lipidol 2005 0.75
113 [Dyslipidemias and cardiovascular diseases: towards a new perspective]. Rev Med Suisse Romande 2002 0.75
114 [Dyslipidemia and metabolic syndrome]. Rev Med Suisse Romande 2002 0.75
115 Prevalence and characteristics of homeopathy users in a representative sample of the Lausanne population: CoLaus study. Pharmacoepidemiol Drug Saf 2008 0.75
116 LDLs induce fibroblast spreading independently of the LDL receptor via activation of the p38 MAPK pathway. J Lipid Res 2003 0.75